Biopsy Devices Market Global Forecast 2021-2027, Impact of COVID-19, Size, Share, Insight, Growth, Opportunity Company Analysis
Worldwide, there is an increase in detection of cancer incidences, of Breast cancer, Prostate cancer, and Lung cancer, due to a rise in awareness level. Besides rapid technological advancements such as 3D optical biopsies, MRI-targeted biopsies, and Ultrasound-guided biopsies fuel the adoption of biopsy devices. Many countries hold programs for the early diagnosis of breast cancer. Therefore, such initiatives will stimulate the adoption rate of biopsy devices, thereby positively impacting the growth of the biopsy devices business. According to Renub Research, the Global Biopsy Devices Market is projected to reach US$ 3.5 Billion by 2027.
With improved screening and diagnostic techniques, biopsy devices are an integral part of the diagnostic workup for many medical conditions. It is a procedure to perform surgical removal of tissue from an organ to determine the presence or extent of disease, usually cancerous and inflammatory conditions. This diagnostic procedure is performed by radiologists, surgeons and interventional cardiologists. Biopsies can be done on any organ using specific biopsy devices as a confirmatory test for cancer and celiac diseases. According to the World Cancer Report, cancer rates could further increase by 50% to 15 Million new cases in 2020. Therefore, the increasing incidence of cancer cases and developments in biopsy devices witness high growth.
Based on Product - Needle-based Biopsy holds the Largest Market Share
The biopsy devices market has been segmented into Biopsy Needles, Guidance Systems, Biopsy Guns, Reagents and others. Needle-based biopsy holds the leading market share due to the increasing demand for Fine Aspiration Needles and Core Needles for acquiring samples from soft tissues of internal organs, an application such as breasts, Prostate, and lungs. As per Statista, breast cancer will make up to 27.7 percent of all the new cancer cases in women in Asia in 2020.
In addition, Guidance Systems, Biopsy Guns, Reagents and other devices are used in extensive applications across numerous healthcare institutions, such as Diagnostic Center, Hospitals and others. Advanced healthcare infrastructure and the expanding prevalence of infections have positively impacted biopsy devices growth over the projected timeframe. This is attributed to the growth in the healthcare sector in emerging economies, the rise in out-of-pocket healthcare expenditure, and the increase in the number of hospitals. As per this research report, Worldwide Biopsy Devices Market is likely to grow at a CAGR of 6.86% by 2021 - 2027.
Regional Analysis – North America is the leading revenue contributor in the Biopsy Devices Industry
Further, North America is the leading revenue contributor in the biopsy devices market. It is due to the large availability of trained medical professionals, well-developed infrastructure facilities, and the presence of a majority of key players. Moreover, Asia Pacific is a promising destination for biopsy device manufacturers. Rapidly improving healthcare infrastructure in emerging Asia Pacific countries, coupled with high unmet patient needs and increasing incidence of breast cancer, is anticipated to stimulate the demand for biopsy devices. Our research suggests that the Global Biopsy Devices Market was US$ 2.2 Billion in 2020.
Company Analysis
Companies are undertaking strategies, such as product launches within technological innovations and partnerships, to gain profits in the industry. For example: In 2021, Oprah Winfrey Network OWN YOUR HEALTH announced an exclusive partnership with Hologic’s Project. This partnership will bring awareness to the inequality of healthcare U.S. Black women get in the areas of breast, cervical, and uterine fibroids. It will give access to education and preventative tools using Hologic’s comprehensive research and resources. Besides, it will also share original content from celebrated OWN creative visionaries highlighting the authentic stories and voices of Black women.
Renub Research latest report “Biopsy Devices Market by Product (Biopsy Needles - Fine Aspiration Needles, Core Needles, Guidance Systems- Ultrasound-guided, Stereotactic-guided, Clinically-guided, Biopsy Guns, Reagents and kits, Others (Brushes, Curettes and Punches etc), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy, Others), Region ( North America, Europe, Asia Pacific, Rest of World), End – User (Diagnostic Center, Hospitals and others), Companies (Becton Dickinson and Company, Cardinal Health. Braun Melsungen AG, Inc, Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Hologic, Inc.)"
Product - Biopsy Devices Market has been covered from 5 Viewpoints:
1. Biopsy Needles
o Fine Aspiration Needles
o Core Needles
2. Guidance Systems
o Ultrasound-guided
o Stereotactic-guided
o Clinically-guided
3. Biopsy Guns
4. Reagents and kits
5. Others (Brushes, Curettes and Punches etc)
Application - Biopsy Devices Market has been covered from 4 Viewpoints:
1. Breast Biopsy
2. Lung Biopsy
3. Prostate Biopsy
4. Others
Region - Biopsy Devices Market has been covered from 4 Viewpoints:
1. North America
2. Europe
3. Asia-Pacific
4. Rest of World
End - User - Biopsy Devices Market has been covered from 3 Viewpoints:
1. Diagnostic Center
2. Hospitals
3. Others
Company Insights:
Overview
Company Initiatives
Sales Analysis
Companies Covered:
1. Becton Dickinson and Company
2. Cardinal Health Inc.
3. Braun Melsungen AG, Inc
4. Olympus Corporation
5. Boston Scientific Corporation
6. Medtronic plc
7. Hologic, Inc.
With improved screening and diagnostic techniques, biopsy devices are an integral part of the diagnostic workup for many medical conditions. It is a procedure to perform surgical removal of tissue from an organ to determine the presence or extent of disease, usually cancerous and inflammatory conditions. This diagnostic procedure is performed by radiologists, surgeons and interventional cardiologists. Biopsies can be done on any organ using specific biopsy devices as a confirmatory test for cancer and celiac diseases. According to the World Cancer Report, cancer rates could further increase by 50% to 15 Million new cases in 2020. Therefore, the increasing incidence of cancer cases and developments in biopsy devices witness high growth.
Based on Product - Needle-based Biopsy holds the Largest Market Share
The biopsy devices market has been segmented into Biopsy Needles, Guidance Systems, Biopsy Guns, Reagents and others. Needle-based biopsy holds the leading market share due to the increasing demand for Fine Aspiration Needles and Core Needles for acquiring samples from soft tissues of internal organs, an application such as breasts, Prostate, and lungs. As per Statista, breast cancer will make up to 27.7 percent of all the new cancer cases in women in Asia in 2020.
In addition, Guidance Systems, Biopsy Guns, Reagents and other devices are used in extensive applications across numerous healthcare institutions, such as Diagnostic Center, Hospitals and others. Advanced healthcare infrastructure and the expanding prevalence of infections have positively impacted biopsy devices growth over the projected timeframe. This is attributed to the growth in the healthcare sector in emerging economies, the rise in out-of-pocket healthcare expenditure, and the increase in the number of hospitals. As per this research report, Worldwide Biopsy Devices Market is likely to grow at a CAGR of 6.86% by 2021 - 2027.
Regional Analysis – North America is the leading revenue contributor in the Biopsy Devices Industry
Further, North America is the leading revenue contributor in the biopsy devices market. It is due to the large availability of trained medical professionals, well-developed infrastructure facilities, and the presence of a majority of key players. Moreover, Asia Pacific is a promising destination for biopsy device manufacturers. Rapidly improving healthcare infrastructure in emerging Asia Pacific countries, coupled with high unmet patient needs and increasing incidence of breast cancer, is anticipated to stimulate the demand for biopsy devices. Our research suggests that the Global Biopsy Devices Market was US$ 2.2 Billion in 2020.
Company Analysis
Companies are undertaking strategies, such as product launches within technological innovations and partnerships, to gain profits in the industry. For example: In 2021, Oprah Winfrey Network OWN YOUR HEALTH announced an exclusive partnership with Hologic’s Project. This partnership will bring awareness to the inequality of healthcare U.S. Black women get in the areas of breast, cervical, and uterine fibroids. It will give access to education and preventative tools using Hologic’s comprehensive research and resources. Besides, it will also share original content from celebrated OWN creative visionaries highlighting the authentic stories and voices of Black women.
Renub Research latest report “Biopsy Devices Market by Product (Biopsy Needles - Fine Aspiration Needles, Core Needles, Guidance Systems- Ultrasound-guided, Stereotactic-guided, Clinically-guided, Biopsy Guns, Reagents and kits, Others (Brushes, Curettes and Punches etc), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy, Others), Region ( North America, Europe, Asia Pacific, Rest of World), End – User (Diagnostic Center, Hospitals and others), Companies (Becton Dickinson and Company, Cardinal Health. Braun Melsungen AG, Inc, Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Hologic, Inc.)"
Product - Biopsy Devices Market has been covered from 5 Viewpoints:
1. Biopsy Needles
o Fine Aspiration Needles
o Core Needles
2. Guidance Systems
o Ultrasound-guided
o Stereotactic-guided
o Clinically-guided
3. Biopsy Guns
4. Reagents and kits
5. Others (Brushes, Curettes and Punches etc)
Application - Biopsy Devices Market has been covered from 4 Viewpoints:
1. Breast Biopsy
2. Lung Biopsy
3. Prostate Biopsy
4. Others
Region - Biopsy Devices Market has been covered from 4 Viewpoints:
1. North America
2. Europe
3. Asia-Pacific
4. Rest of World
End - User - Biopsy Devices Market has been covered from 3 Viewpoints:
1. Diagnostic Center
2. Hospitals
3. Others
Company Insights:
Overview
Company Initiatives
Sales Analysis
Companies Covered:
1. Becton Dickinson and Company
2. Cardinal Health Inc.
3. Braun Melsungen AG, Inc
4. Olympus Corporation
5. Boston Scientific Corporation
6. Medtronic plc
7. Hologic, Inc.
1. INTRODUCTION
2. RESEARCH & METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Growth Drivers
4.2 Challenges
5. GLOBAL BIOPSY DEVICES MARKET
6. MARKET SHARE – GLOBAL BIOPSY DEVICES
6.1 By Product
6.2 By Application
6.3 By Region
6.4 By End-User
7. PRODUCT - BIOPSY DEVICES MARKET
7.1 Biopsy Needles
7.1.1 Fine Aspiration Needles
7.1.2 Core Needles
7.2 Guidance Systems
7.2.1 Ultrasound-guided
7.2.2 Stereotactic-guided
7.2.3 Clinically-guided
7.3 Biopsy Guns
7.4 Reagents and kits
7.5 Others (Brushes, Curettes and Punches etc)
8. APPLICATION - BIOPSY DEVICES MARKET
8.1 Breast Biopsy
8.2 Lung Biopsy
8.3 Prostate Biopsy
8.4 Others
9. REGION - BIOPSY DEVICES MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Rest of World
10. END USER - BIOPSY DEVICES MARKET
10.1 Diagnostic Center
10.2 Hospitals
10.3 Others
11. COMPANY ANALYSIS
11.1 Becton, Dickinson and Company
11.1.1 Overview
11.1.2 Recent Development
11.1.3 Financial Insight
11.2 B. Braun Melsungen AG
11.2.1 Overview
11.2.2 Key Development
11.2.3 Financial Insight
11.3 Cardinal Health, Inc.
11.3.1 Overview
11.3.2 Key Development
11.3.3 Financial Insight
11.4 Olympus Corporation
11.4.1 Overview
11.4.2 Key Development
11.4.3 Financial Insight
11.5 Boston Scientific Corporation
11.5.1 Overview
11.5.2 Key Development
11.5.3 Financial Insight
11.6 Medtronic plc
11.6.1 Overview
11.6.2 Key Development
11.6.3 Financial Insight
11.7 Hologic, Inc.
11.7.1 Overview
11.7.2 Key Development
11.7.3 Financial Insight
2. RESEARCH & METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Growth Drivers
4.2 Challenges
5. GLOBAL BIOPSY DEVICES MARKET
6. MARKET SHARE – GLOBAL BIOPSY DEVICES
6.1 By Product
6.2 By Application
6.3 By Region
6.4 By End-User
7. PRODUCT - BIOPSY DEVICES MARKET
7.1 Biopsy Needles
7.1.1 Fine Aspiration Needles
7.1.2 Core Needles
7.2 Guidance Systems
7.2.1 Ultrasound-guided
7.2.2 Stereotactic-guided
7.2.3 Clinically-guided
7.3 Biopsy Guns
7.4 Reagents and kits
7.5 Others (Brushes, Curettes and Punches etc)
8. APPLICATION - BIOPSY DEVICES MARKET
8.1 Breast Biopsy
8.2 Lung Biopsy
8.3 Prostate Biopsy
8.4 Others
9. REGION - BIOPSY DEVICES MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Rest of World
10. END USER - BIOPSY DEVICES MARKET
10.1 Diagnostic Center
10.2 Hospitals
10.3 Others
11. COMPANY ANALYSIS
11.1 Becton, Dickinson and Company
11.1.1 Overview
11.1.2 Recent Development
11.1.3 Financial Insight
11.2 B. Braun Melsungen AG
11.2.1 Overview
11.2.2 Key Development
11.2.3 Financial Insight
11.3 Cardinal Health, Inc.
11.3.1 Overview
11.3.2 Key Development
11.3.3 Financial Insight
11.4 Olympus Corporation
11.4.1 Overview
11.4.2 Key Development
11.4.3 Financial Insight
11.5 Boston Scientific Corporation
11.5.1 Overview
11.5.2 Key Development
11.5.3 Financial Insight
11.6 Medtronic plc
11.6.1 Overview
11.6.2 Key Development
11.6.3 Financial Insight
11.7 Hologic, Inc.
11.7.1 Overview
11.7.2 Key Development
11.7.3 Financial Insight
LIST OF FIGURES:
Figure-01: Global Biopsy Devices Market (Million US$), 2016 – 2020
Figure-02: Forecast for – Global Biopsy Devices Market (Million US$), 2021 – 2027
Figure-03: Product – Biopsy Needles Market (Million US$), 2016 – 2020
Figure-04: Product – Forecast for Biopsy Needles Market (Million US$), 2021 – 2027
Figure-05: Product – Fine Aspiration Needles Market (Million US$), 2016 – 2020
Figure-06: Product – Forecast for Fine Aspiration Needles Market (Million US$), 2021 – 2030
Figure-07: Product – Core Needles Market (Million US$), 2016 – 2020
Figure-08: Product – Forecast for Core Needles Market (Million US$), 2021 – 2030
Figure-09: Product – Guidance Systems Market (Million US$), 2016 – 2020
Figure-10: Product – Forecast for Guidance Systems Market (Million US$), 2021 – 2027
Figure-11: Product – Ultrasound-guided Market (Million US$), 2016 – 2020
Figure-12: Product – Forecast for Ultrasound-guided Market (Million US$), 2021 – 2030
Figure-13: Product – Stereotactic-guided Market (Million US$), 2016 – 2020
Figure-14: Product – Forecast for Stereotactic-guided Market (Million US$), 2021 – 2030
Figure-15: Product – Clinically-guided Market (Million US$), 2016 – 2020
Figure-16: Product – Forecast for Clinically-guided Market (Million US$), 2021 – 2030
Figure-17: Product – Biopsy Guns Market (Million US$), 2016 – 2020
Figure-18: Product – Forecast for Biopsy Guns Market (Million US$), 2021 – 2027
Figure-19: Product – Reagents and kits Market (Million US$), 2016 – 2020
Figure-20: Product – Forecast for Reagents and kits Market (Million US$), 2021 – 2027
Figure-21: Product – Others (Brushes, Curettes and Punches etc) Market (Million US$), 2016 – 2020
Figure-22: Product – Forecast for Others (Brushes, Curettes and Punches etc) Market (Million US$), 2021 – 2027
Figure-23: Application – Breast Biopsy Market (Million US$), 2016 – 2020
Figure-24: Application – Forecast for Breast Biopsy Market (Million US$), 2021 – 2027
Figure-25: Application – Lung Biopsy Market (Million US$), 2016 – 2020
Figure-26: Application – Forecast for Lung Biopsy Market (Million US$), 2021 – 2027
Figure-27: Application – Prostate Biopsy Market (Million US$), 2016 – 2020
Figure-28: Application – Forecast for Prostate Biopsy Market (Million US$), 2021 – 2027
Figure-29: Application – Others Market (Million US$), 2016 – 2020
Figure-30: Application – Forecast for Others Market (Million US$), 2021 – 2027
Figure-31: North America – Biopsy Devices Market (Million US$), 2016 – 2020
Figure-32: North America – Forecast for Biopsy Devices Market (Million US$), 2021 – 2027
Figure-33: Europe – Biopsy Devices Market (Million US$), 2016 – 2020
Figure-34: Europe – Forecast for Biopsy Devices Market (Million US$), 2021 – 2027
Figure-35: Asia Pacific – Biopsy Devices Market (Million US$), 2016 – 2020
Figure-36: Asia Pacific – Forecast for Biopsy Devices Market (Million US$), 2021 – 2027
Figure-37: Rest of World – Biopsy Devices Market (Million US$), 2016 – 2020
Figure-38: Rest of World – Forecast for Biopsy Devices Market (Million US$), 2021 – 2027
Figure-39: End - Use – Diagnostic Center Market (Million US$), 2016 – 2020
Figure-40: End - Use – Forecast for Diagnostic Center Market (Million US$), 2021 – 2027
Figure-41: End - Use – Hospitals Market (Million US$), 2016 – 2020
Figure-42: End - Use – Forecast for Hospitals Market (Million US$), 2021 – 2027
Figure-43: End - Use – Others Market (Million US$), 2016 – 2020
Figure-44: End - Use – Forecast for Others Market (Million US$), 2021 – 2027
Figure-45: Becton, Dickinson and Company – Global Revenue (Million US$), 2016 – 2020
Figure-46: Becton, Dickinson and Company – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-47: B. Braun Melsungen AG – Global Revenue (Million US$), 2016 – 2020
Figure-48: B. Braun Melsungen AG – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-49: Cardinal Health, Inc. – Global Revenue (Million US$), 2016 – 2020
Figure-50: Cardinal Health, Inc. – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-51: Olympus Corporation – Global Revenue (Million US$), 2016 – 2020
Figure-52: Olympus Corporation – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-53: Boston Scientific Corporation – Global Revenue (Million US$), 2016 – 2020
Figure-54: Boston Scientific Corporation – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-55: Medtronic plc – Global Revenue (Million US$), 2016 – 2020
Figure-56: Medtronic plc – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-57: Nvidia Corporation – Global Revenue (Million US$), 2016 – 2020
Figure-58: Nvidia Corporation – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-01: Global Biopsy Devices Market (Million US$), 2016 – 2020
Figure-02: Forecast for – Global Biopsy Devices Market (Million US$), 2021 – 2027
Figure-03: Product – Biopsy Needles Market (Million US$), 2016 – 2020
Figure-04: Product – Forecast for Biopsy Needles Market (Million US$), 2021 – 2027
Figure-05: Product – Fine Aspiration Needles Market (Million US$), 2016 – 2020
Figure-06: Product – Forecast for Fine Aspiration Needles Market (Million US$), 2021 – 2030
Figure-07: Product – Core Needles Market (Million US$), 2016 – 2020
Figure-08: Product – Forecast for Core Needles Market (Million US$), 2021 – 2030
Figure-09: Product – Guidance Systems Market (Million US$), 2016 – 2020
Figure-10: Product – Forecast for Guidance Systems Market (Million US$), 2021 – 2027
Figure-11: Product – Ultrasound-guided Market (Million US$), 2016 – 2020
Figure-12: Product – Forecast for Ultrasound-guided Market (Million US$), 2021 – 2030
Figure-13: Product – Stereotactic-guided Market (Million US$), 2016 – 2020
Figure-14: Product – Forecast for Stereotactic-guided Market (Million US$), 2021 – 2030
Figure-15: Product – Clinically-guided Market (Million US$), 2016 – 2020
Figure-16: Product – Forecast for Clinically-guided Market (Million US$), 2021 – 2030
Figure-17: Product – Biopsy Guns Market (Million US$), 2016 – 2020
Figure-18: Product – Forecast for Biopsy Guns Market (Million US$), 2021 – 2027
Figure-19: Product – Reagents and kits Market (Million US$), 2016 – 2020
Figure-20: Product – Forecast for Reagents and kits Market (Million US$), 2021 – 2027
Figure-21: Product – Others (Brushes, Curettes and Punches etc) Market (Million US$), 2016 – 2020
Figure-22: Product – Forecast for Others (Brushes, Curettes and Punches etc) Market (Million US$), 2021 – 2027
Figure-23: Application – Breast Biopsy Market (Million US$), 2016 – 2020
Figure-24: Application – Forecast for Breast Biopsy Market (Million US$), 2021 – 2027
Figure-25: Application – Lung Biopsy Market (Million US$), 2016 – 2020
Figure-26: Application – Forecast for Lung Biopsy Market (Million US$), 2021 – 2027
Figure-27: Application – Prostate Biopsy Market (Million US$), 2016 – 2020
Figure-28: Application – Forecast for Prostate Biopsy Market (Million US$), 2021 – 2027
Figure-29: Application – Others Market (Million US$), 2016 – 2020
Figure-30: Application – Forecast for Others Market (Million US$), 2021 – 2027
Figure-31: North America – Biopsy Devices Market (Million US$), 2016 – 2020
Figure-32: North America – Forecast for Biopsy Devices Market (Million US$), 2021 – 2027
Figure-33: Europe – Biopsy Devices Market (Million US$), 2016 – 2020
Figure-34: Europe – Forecast for Biopsy Devices Market (Million US$), 2021 – 2027
Figure-35: Asia Pacific – Biopsy Devices Market (Million US$), 2016 – 2020
Figure-36: Asia Pacific – Forecast for Biopsy Devices Market (Million US$), 2021 – 2027
Figure-37: Rest of World – Biopsy Devices Market (Million US$), 2016 – 2020
Figure-38: Rest of World – Forecast for Biopsy Devices Market (Million US$), 2021 – 2027
Figure-39: End - Use – Diagnostic Center Market (Million US$), 2016 – 2020
Figure-40: End - Use – Forecast for Diagnostic Center Market (Million US$), 2021 – 2027
Figure-41: End - Use – Hospitals Market (Million US$), 2016 – 2020
Figure-42: End - Use – Forecast for Hospitals Market (Million US$), 2021 – 2027
Figure-43: End - Use – Others Market (Million US$), 2016 – 2020
Figure-44: End - Use – Forecast for Others Market (Million US$), 2021 – 2027
Figure-45: Becton, Dickinson and Company – Global Revenue (Million US$), 2016 – 2020
Figure-46: Becton, Dickinson and Company – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-47: B. Braun Melsungen AG – Global Revenue (Million US$), 2016 – 2020
Figure-48: B. Braun Melsungen AG – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-49: Cardinal Health, Inc. – Global Revenue (Million US$), 2016 – 2020
Figure-50: Cardinal Health, Inc. – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-51: Olympus Corporation – Global Revenue (Million US$), 2016 – 2020
Figure-52: Olympus Corporation – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-53: Boston Scientific Corporation – Global Revenue (Million US$), 2016 – 2020
Figure-54: Boston Scientific Corporation – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-55: Medtronic plc – Global Revenue (Million US$), 2016 – 2020
Figure-56: Medtronic plc – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-57: Nvidia Corporation – Global Revenue (Million US$), 2016 – 2020
Figure-58: Nvidia Corporation – Forecast for Global Revenue (Million US$), 2021 – 2027
LIST OF TABLES:
Table-01: Biopsy Devices Market Share by Product (Percent), 2016 – 2020
Table-02: Forecast for – Biopsy Devices Market Share by Product (Percent), 2021 – 2027
Table-03: Biopsy Devices Market Share by Application (Percent), 2016 – 2020
Table-04: Forecast for – Biopsy Devices Market Share by Application (Percent), 2021 – 2027
Table-05: Biopsy Devices Market Share by Region (Percent), 2016 – 2020
Table-06: Forecast for – Biopsy Devices Market Share by Region (Percent), 2021 – 2027
Table-07: Biopsy Devices Market Share by End-User (Percent), 2016 – 2020
Table-08: Forecast for – Biopsy Devices Market Share by End-User (Percent), 2021 – 2027
Table-01: Biopsy Devices Market Share by Product (Percent), 2016 – 2020
Table-02: Forecast for – Biopsy Devices Market Share by Product (Percent), 2021 – 2027
Table-03: Biopsy Devices Market Share by Application (Percent), 2016 – 2020
Table-04: Forecast for – Biopsy Devices Market Share by Application (Percent), 2021 – 2027
Table-05: Biopsy Devices Market Share by Region (Percent), 2016 – 2020
Table-06: Forecast for – Biopsy Devices Market Share by Region (Percent), 2021 – 2027
Table-07: Biopsy Devices Market Share by End-User (Percent), 2016 – 2020
Table-08: Forecast for – Biopsy Devices Market Share by End-User (Percent), 2021 – 2027
